Dark Forest Capital Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-183,505
Closed -$1.91M 978
2025
Q4
$1.91M Buy
+183,505
New +$1.93M 0.09% 408
2025
Q1
Sell
-17,538
Closed -$153K 1340
2024
Q4
$153K Buy
+17,538
New +$252K 0.02% 833
2023
Q4
Sell
-80,162
Closed -$731K 808
2023
Q3
$731K Buy
+80,162
New +$814K 0.06% 548
2023
Q1
Sell
-970
Closed -$12K 1338
2022
Q4
$12K Sell
970
-2,229
-70% -$32.4K ﹤0.01% 699
2022
Q3
$44K Buy
3,199
+3,192
+45,600% +$49.2K 0.01% 532
2022
Q2
$0 Buy
+7
New +$101 ﹤0.01% 1145

Other funds holding KURA

Dark Forest Capital Management's KURA Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 183,505 shares — an estimated $1.91M sold.

Dark Forest Capital Management first reported a position in KURA in Q2 2022 and held it in 6 quarters. The position peaked at $1.91M in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 183,505 Kura Oncology shares in Q1 2026, an estimated $1.91M.
  • Dark Forest Capital Management first reported a position in Kura Oncology in Q2 2022 and held it in 6 quarters.
  • Dark Forest Capital Management's Kura Oncology position peaked at $1.91M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.